Skellys Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2010.

2010 Mumbai, Maharashtra, India Struck Off

Last Updated: July 23, 2025

About Skellys Pharmaceuticals Private Limited

Skellys Pharmaceuticals Private Limited, a struck off private limited company, was established on 19 July 2010 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239MH2010PTC205595. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sridhar Muthuramaswamy (Director), Geetha Vivek Naidu (Director), Vivekanand Narayanswami Naidu (Director). It is based at 2, Sai Ram Apartment Mhada Colony, Mulund East,, Mumbai, Maharashtra, 400081.

Company Details

CIN/LLPIN
U24239MH2010PTC205595
Registration Number
205595
Incorporation Date
19 July 2010
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.10 M as on 23-07-2025
Paid Up Capital ₹ 0.10 M as on 23-07-2025
Company Age 15 Year, 6 Months

Comprehensive Company Insights

Explore comprehensive insights into Skellys Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Skellys Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sridhar Muthuramaswamy	Director	19 Jul 2010	Current
Geetha Vivek Naidu	Director	19 Jul 2010	Current
Vivekanand Narayanswami Naidu	Director	19 Jul 2010	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skellys Pharmaceuticals.

Enhance accessibility to Skellys Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skellys Pharmaceuticals?

Unlock access to Skellys Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skellys Pharmaceuticals?

Unlock and access historical data on people associated with Skellys Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Skellys Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skellys Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skellys Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Progress on Sridhar Muthuramaswamy was appointed as a Director was appointed as a Director on 19 Jul 2010 & has been associated with this company since 15 years 6 months . was documented.
19 Jul 2010
Director Appointment

Progress on Geetha Vivek Naidu was appointed as a Director was appointed as a Director on 19 Jul 2010 & has been associated with this company since 15 years 6 months . was documented.
19 Jul 2010
Director Appointment

Progress on Vivekanand Narayanswami Naidu was appointed as a Director was appointed as a Director on 19 Jul 2010 & has been associated with this company since 15 years 6 months . was documented.
19 Jul 2010
Company Incorporation

Skellys Pharmaceuticals Private Limited was registered on 19 Jul 2010 with Roc Mumbai & aged 15 years 6 months as per MCA records. was recorded as a recent event.
19 Jul 2010

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Skellys Pharmaceuticals Private Limited?

The CIN of Skellys Pharmaceuticals Private Limited is U24239MH2010PTC205595.

Where is Skellys Pharmaceuticals Private Limited headquartered?

Skellys Pharmaceuticals Private Limited is headquartered at 2, Sai Ram Apartment Mhada Colony, Mulund East,, Mumbai, Maharashtra, 400081.

When was Skellys Pharmaceuticals Private Limited incorporated?

Skellys Pharmaceuticals Private Limited was incorporated on 19 July 2010.

Who are the current directors of Skellys Pharmaceuticals Private Limited?

The current directors of Skellys Pharmaceuticals Private Limited are

What is the primary industry of Skellys Pharmaceuticals Private Limited?

The primary industry of Skellys Pharmaceuticals Private Limited is Chemicals.

Is Skellys Pharmaceuticals Private Limited a listed company?

Skellys Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Skellys Pharmaceuticals Private Limited?

The authorized capital of Skellys Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available